<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Profiling the TME of PDAC Tumor Homografts

Pancreatic ductal adenocarcinoma (PDAC) does not respond to a range of cancer therapies (e.g. chemo-, targeted, and immunotherapy), partially due to an abundant tumor microenvironment (TME), that protects tumor cells from treatment.